{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:06:23Z","timestamp":1793124383600,"version":"4.5.0"},"reference-count":53,"publisher":"MDPI AG","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:title\/>\n                  <jats:sec id=\"st1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recognizing the existence of adverse drug effects of frequently prescribed drugs can empower a clinician with knowledge to avoid dangerous adverse effects that may result in hazardous, negative patient outcomes on either fracture healing or bone health. Pharmacovigilance reports have described the influence of medications, allowing for bone health to be quite unpredictable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>First, mechanisms found in the medical literature of potential drug adverse effects regarding fracture healing are presented. Second, the 100 most frequently prescribed medications in 2010 are reviewed regarding adverse effects on fracture healing. These reported adverse effects are evaluated for medical causation. Last, a data table describing the 100 reviewed medications and their reported effects on fracture healing is provided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The actual number of different medications in the review was 72. Reported drug adverse effects on bone and fracture healing occurred with 59 of the 72 drugs (81.9%). These adverse effects are either described as a definitive statement or represented by postmarketing case reports. Thirteen of the 72 review drugs (18.1%) did not have any description of the possible effects on bone health. A total of 301 cases reports describing delayed union, malunion, and nonunion of fractures represent 31 of the 72 medications reviewed (43.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review offers the health-care provider information regarding potential adverse drug effects on bone health. Empowered with this information, clinicians may assist their patients in maximizing pharmacologic outcomes by avoiding these reported harmful adverse effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7547\/0003-0538-105.2.160","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T11:27:21Z","timestamp":1427455641000},"page":"160-172","source":"Crossref","is-referenced-by-count":2,"title":["Fracture Healing"],"prefix":"10.3390","volume":"105","author":[{"given":"Robert G.","family":"Smith","sequence":"first","affiliation":[{"name":"Shoe String Podiatry, 723 Lucerne Cir, Ormond Beach, FL 32174. (E-mail: ASamaan@cfl.rr.com)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"i8750-7315-105-2-160-b01","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2106\/JBJS.I.01649","article-title":"Development of a prognostic na\u00efve Bayesian classifer for successful treatment of nonunions","volume":"93","author":"Stojadinovic\n              A,","year":"2011","unstructured":"Stojadinovic\n              A, \n            \n              Potter\n              BK, \n            \n              Eberhardt\n              J, \n            et al\n          : Development of a prognostic na\u00efve Bayesian classifer for successful treatment of nonunions. J Bone Joint Surg Am93: 187, 2011.10.2106\/JBJS.I.01649"},{"key":"i8750-7315-105-2-160-b02","series-title":"Clin Orthop","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00003086-199507000-00003","article-title":"Osteoporosis and aging: current update","volume":"316","author":"Silver\n              JJ,","year":"1995","unstructured":"Silver\n              JJ, \n            \n              Einhorn\n              TA:\n            \n          \n          Osteoporosis and aging: current update. Clin Orthop316: 10, 1995.10.1097\/00003086-199507000-00003"},{"issue":"suppl 1","key":"i8750-7315-105-2-160-b03","series-title":"Injury","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.injury.2007.02.014","article-title":"Fracture healing in osteoporotic fractures: is it really different? a basic science perspective","volume":"38","author":"Giannoudis\n              P,","year":"2007","unstructured":"Giannoudis\n              P, \n            \n              Tzioupis\n              C, \n            \n              Almalki\n              T, \n            et al\n          : Fracture healing in osteoporotic fractures: is it really different? a basic science perspective. Injury38 (suppl 1): S90, 2007.1738349010.1016\/j.injury.2007.02.014"},{"key":"i8750-7315-105-2-160-b04","series-title":"Curr Drug Safety","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/157488607779315516","article-title":"Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases","volume":"2","author":"Conforti\n              A,","year":"2007","unstructured":"Conforti\n              A, \n            \n              Chimaulera\n              C, \n            \n              Moretti\n              U, \n            et al\n          : Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases. Curr Drug Safety2: 47, 2007.10.2174\/157488607779315516"},{"key":"i8750-7315-105-2-160-b05","series-title":"Am J Med","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: mechanisms and clinical implications","volume":"123","author":"Mazziotti\n              G,","year":"2010","unstructured":"Mazziotti\n              G, \n            \n              Canalis\n              E, \n            \n              Giustina\n              A:\n            \n          \n          Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med123: 877, 2010.2092068510.1016\/j.amjmed.2010.02.028"},{"key":"i8750-7315-105-2-160-b06","series-title":"Guidance Document for the Preparation of Investigational Device Exemptions and Pre-market Approval Applications for Bone Growth Stimulator Devices,","year":"1988","unstructured":"Guidance Document for the Preparation of Investigational Device Exemptions and Pre-market Approval Applications for Bone Growth Stimulator Devices,\n          US Food and Drug Administration, Rockville, MD, 1988."},{"key":"i8750-7315-105-2-160-b07","series-title":"Surgical Treatment of Orthopaedic Trauma","article-title":"\u201cTreatment Strategy for Nonunions and Malunions,\u201d","author":"Miranda\n              MA,","year":"2007","unstructured":"Miranda\n              MA, \n            \n              Moon\n              MS:\n            \n          \n          \u201cTreatment Strategy for Nonunions and Malunions,\u201d\n          in\n          Surgical Treatment of Orthopaedic Trauma, edited byJPStannard, AHSchmidt, PJKregor, Theime Medical Publishers, New York, 2007."},{"key":"i8750-7315-105-2-160-b08","series-title":"J Am Acad Orthop Surg","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5435\/JAAOS-20-05-273","article-title":"Assessment of compromised fracture healing","volume":"20","author":"Bishop\n              JA,","year":"2012","unstructured":"Bishop\n              JA, \n            \n              Palanca\n              AA, \n            \n              Bellino\n              MJ, \n            et al\n          : Assessment of compromised fracture healing. J Am Acad Orthop Surg20: 273, 2012.10.5435\/JAAOS-20-05-27322553099"},{"key":"i8750-7315-105-2-160-b09","series-title":"J Bone Joint Surg Br","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1302\/0301-620X.89B12.19671","article-title":"Inhibition of fracture healing","volume":"89","author":"Gaston\n              MS,","year":"2007","unstructured":"Gaston\n              MS, \n            \n              Simpson\n              AH:\n            \n          \n          Inhibition of fracture healing. J Bone Joint Surg Br89: 1553, 2007.1805735210.1302\/0301-620X.89B12.19671"},{"key":"i8750-7315-105-2-160-b10","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2106\/00004623-200407000-00002","article-title":"Estimating the risk of nonunion following nonoperative treatment of a clavicular fracture","volume":"86","author":"Robinson\n              CM,","year":"2004","unstructured":"Robinson\n              CM, \n            \n              Court-Brown\n              CM, \n            \n              McQueen\n              MM, \n            et al\n          : Estimating the risk of nonunion following nonoperative treatment of a clavicular fracture. J Bone Joint Surg Am86: 1359, 2004.10.2106\/00004623-200407000-0000215252081"},{"key":"i8750-7315-105-2-160-b11","series-title":"Curr Orthop","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cuor.2007.06.004","article-title":"Factors contributing to non-union of fractures","volume":"21","author":"Perumal\n              V,","year":"2007","unstructured":"Perumal\n              V, \n            \n              Roberts\n              CS:\n            \n          \n          Factors contributing to non-union of fractures. Curr Orthop21: 258, 2007.10.1016\/j.cuor.2007.06.004"},{"key":"i8750-7315-105-2-160-b12","series-title":"Health, United States, 2010: With Special Feature on Death and Dying","year":"2011","unstructured":"National Center for Health Statistics: Health, United States, 2010: With Special Feature on Death and Dying, National Center for Health Statistics, Hyattsville, MD, 2011."},{"key":"i8750-7315-105-2-160-b13","series-title":"The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products,","year":"2002","unstructured":"World Health Organization: The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products,World Health Organization, Geneva, Switzerland, 2002. Available at: http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js4893e\/6.html. Accessed May 14, 2012."},{"key":"i8750-7315-105-2-160-b14","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality","volume":"277","author":"Classen\n              DC,","year":"1997","unstructured":"Classen\n              DC, \n            \n              Pestotnik\n              SL, \n            \n              Evans\n              RS, \n            et al\n          : Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA277: 301, 1997.10.1001\/jama.1997.035402800390319002492"},{"key":"i8750-7315-105-2-160-b15","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/bmj.316.7140.1295","article-title":"Adverse drug reactions","volume":"316","author":"Pirmohamed\n              M,","year":"1998","unstructured":"Pirmohamed\n              M, \n            \n              Breckenridge\n              AM, \n            \n              Kitteringham\n              NR, \n            et al\n          : Adverse drug reactions. BMJ316: 1295, 1998.955490210.1136\/bmj.316.7140.1295"},{"key":"i8750-7315-105-2-160-b16","series-title":"Br J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"105S","DOI":"10.1111\/j.1365-2125.1981.tb01845.x","article-title":"Difficulties in assessing the adverse effects of drugs","volume":"11","author":"Kramer\n              MS:","year":"1981","unstructured":"Kramer\n              MS:\n            \n          \n          Difficulties in assessing the adverse effects of drugs. Br J Clin Pharmacol11: 105S, 1981.10.1111\/j.1365-2125.1981.tb01845.x7052788"},{"key":"i8750-7315-105-2-160-b17","series-title":"Drug Injury: Liability, Analysis and Prevention","first-page":"143","article-title":"\u201cEvaluation of Medical Causation,\u201d","author":"Marks\n              DH:","year":"2005","unstructured":"Marks\n              DH:\n            \n          \n          \u201cEvaluation of Medical Causation,\u201d\n          in\n          Drug Injury: Liability, Analysis and Prevention, 2nd Ed, edited byJTO'Donnell, p143, Lawyers & Judges Publishing Co Inc, Tucson, AZ, 2005."},{"key":"i8750-7315-105-2-160-b18","series-title":"J Clin Epidemiol","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0895-4356(89)90020-6","article-title":"Assessing methods for causality assessment","volume":"42","author":"Hutchinson\n              TA,","year":"1989","unstructured":"Hutchinson\n              TA, \n            \n              Lane\n              DA:\n            \n          \n          Assessing methods for causality assessment. J Clin Epidemiol42: 5, 1989.10.1016\/0895-4356(89)90020-62913186"},{"key":"i8750-7315-105-2-160-b19","series-title":"Proc R Soc Med","first-page":"293","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill\n              AB:","year":"1965","unstructured":"Hill\n              AB:\n            \n          \n          The environment and disease: association or causation?\n          Proc R Soc Med\n          58: 293, 1965."},{"key":"i8750-7315-105-2-160-b20","series-title":"eHealthMe Web site","year":"2012","unstructured":"eHealthMe Web site. Available at: http:\/\/www.ehealthme.com. Accessed May 21, 2012."},{"key":"i8750-7315-105-2-160-b21","series-title":"Press release","article-title":"IMS Institute reports U.S. spending on medicines grew 2.3 percent in 2010, to $307.4 billion","year":"2011","unstructured":"IMS Institute for Healthcare Informatics: IMS Institute reports U.S. spending on medicines grew 2.3 percent in 2010, to $307.4 billion. Press release. Available at: http:\/\/www.imshealth.com\/portal\/site\/imshealth\/menuitem.a46c6d4df3db4b3d88f611019418c22a\/?vgnextoid= 1648679328d6f210VgnVCM100000ed152ca2RCRD&vgnextchannel=41a67900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default. Published April 19, 2011. Accessed April 23, 2011."},{"key":"i8750-7315-105-2-160-b22","series-title":"Biol Pharm Bull","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1248\/bpb.24.628","article-title":"Effects of various antihypertensive drugs on the function of osteoblast","volume":"24","author":"Nishiya\n              Y,","year":"2001","unstructured":"Nishiya\n              Y, \n            \n              Sugimoto\n              S:\n            \n          \n          Effects of various antihypertensive drugs on the function of osteoblast. Biol Pharm Bull24: 628, 2001.1141154910.1248\/bpb.24.628"},{"key":"i8750-7315-105-2-160-b23","series-title":"Aging Clin Exp Res","first-page":"112","article-title":"Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease","volume":"23","author":"Sosa\n              M,","year":"2011","unstructured":"Sosa\n              M, \n            \n              Saaveddra\n              P, \n            \n              G\u00f3mez de Tejada\n              MJ, \n            et al\n          : Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease. Aging Clin Exp Res23: 112, 2011.20463439"},{"key":"i8750-7315-105-2-160-b24","series-title":"J Hypertens","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with betablockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark\n              L,","year":"2006","unstructured":"Rejnmark\n              L, \n            \n              Vestergaard\n              P, \n            \n              Mosekilde\n              L:\n            \n          \n          Treatment with betablockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens24: 581, 2006.10.1097\/01.hjh.0000203845.26690.cb"},{"key":"i8750-7315-105-2-160-b25","series-title":"Arthritis Res","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/ar413","article-title":"The role of statins as potential targets for bone formation","volume":"4","author":"Garrett\n              IR,","year":"2002","unstructured":"Garrett\n              IR, \n            \n              Mundy\n              GR:\n            \n          \n          The role of statins as potential targets for bone formation. Arthritis Res4: 237, 2002.1210649310.1186\/ar413"},{"key":"i8750-7315-105-2-160-b26","series-title":"Curr Drug Saf","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/157488608785699469","article-title":"Cardiovascular drugs and bone","volume":"3","author":"Rejnmark\n              L:","year":"2008","unstructured":"Rejnmark\n              L:\n            \n          \n          Cardiovascular drugs and bone. Curr Drug Saf3: 178, 2008.10.2174\/15748860878569946918690998"},{"key":"i8750-7315-105-2-160-b27","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis","volume":"295","author":"Dale\n              KM,","year":"2006","unstructured":"Dale\n              KM, \n            \n              Coleman\n              CI, \n            \n              Henyan\n              NM, \n            et al\n          : Statins and cancer risk: a meta-analysis. JAMA295: 74, 2006.10.1001\/jama.295.1.7416391219"},{"key":"i8750-7315-105-2-160-b28","series-title":"J Orthop Res","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jor.20572","article-title":"Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing","volume":"27","author":"Patil\n              S,","year":"2009","unstructured":"Patil\n              S, \n            \n              Holt\n              G, \n            \n              Raby\n              N, \n            et al\n          : Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing. J Orthop Res27: 281, 2009.1885342810.1002\/jor.20572"},{"key":"i8750-7315-105-2-160-b29","series-title":"Expert Opin Pharmacother","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1517\/14656566.9.7.1169","article-title":"The effect of anticoagulant pharmacotherapy on fracture healing","volume":"9","author":"Lindner\n              T,","year":"2008","unstructured":"Lindner\n              T, \n            \n              Cockbain\n              AJ, \n            \n              El Masry\n              MA, \n            et al\n          : The effect of anticoagulant pharmacotherapy on fracture healing. Expert Opin Pharmacother9: 1169, 2008.10.1517\/14656566.9.7.116918422474"},{"key":"i8750-7315-105-2-160-b30","series-title":"Ann Intern Med","doi-asserted-by":"publisher","first-page":"829","DOI":"10.7326\/0003-4819-128-10-199805150-00006","article-title":"Warfarin use and risk for osteoporosis in elderly women: Study of Osteoporotic Fractures Research Group","volume":"210","author":"Jamal\n              SA,","year":"1998","unstructured":"Jamal\n              SA, \n            \n              Browner\n              WS, \n            \n              Bauer\n              DC, \n            et al\n          : Warfarin use and risk for osteoporosis in elderly women: Study of Osteoporotic Fractures Research Group. Ann Intern Med210: 829, 1998.10.7326\/0003-4819-128-10-199805150-00006"},{"key":"i8750-7315-105-2-160-b31","series-title":"Thromb Res","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0049-3848(02)00035-X","article-title":"Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats","volume":"105","author":"Simon\n              RR,","year":"2002","unstructured":"Simon\n              RR, \n            \n              Beaudin\n              SM, \n            \n              Johnston\n              M, \n            et al\n          : Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats. Thromb Res105: 353, 2002.10.1016\/S0049-3848(02)00035-X12031831"},{"key":"i8750-7315-105-2-160-b32","series-title":"J Intern Med","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","article-title":"Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies","volume":"260","author":"Wiens\n              M,","year":"2006","unstructured":"Wiens\n              M, \n            \n              Etminan\n              M, \n            \n              Gill\n              SS, \n            et al\n          : Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med260: 350, 2006.1696167210.1111\/j.1365-2796.2006.01695.x"},{"key":"i8750-7315-105-2-160-b33","series-title":"J Bone Miner Res","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jbmr.356","article-title":"Risk of fractures in older adults using antihypertensive medications","volume":"26","author":"Solomon\n              DH,","year":"2011","unstructured":"Solomon\n              DH, \n            \n              Mogun\n              H, \n            \n              Garneau\n              K, \n            et al\n          : Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res26: 1561, 2011.2131226810.1002\/jbmr.356"},{"key":"i8750-7315-105-2-160-b34","series-title":"Calcif Tissue Int","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0084-2","article-title":"Reduce fracture risk in users of thiazide diuretics","volume":"76","author":"Rejnmark\n              L,","year":"2005","unstructured":"Rejnmark\n              L, \n            \n              Vestergaard\n              P, \n            \n              Mosekilde\n              L:\n            \n          \n          Reduce fracture risk in users of thiazide diuretics. Calcif Tissue Int76: 167, 2005.10.1007\/s00223-004-0084-215719207"},{"key":"i8750-7315-105-2-160-b35","series-title":"J Intern Med","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","article-title":"Fracture risk in patients treated with loop diuretics","volume":"259","author":"Rejnmark\n              L,","year":"2006","unstructured":"Rejnmark\n              L, \n            \n              Vestergaard\n              P, \n            \n              Mosekilde\n              L:\n            \n          \n          Fracture risk in patients treated with loop diuretics. J Intern Med259: 117, 2006.10.1111\/j.1365-2796.2005.01585.x16336519"},{"key":"i8750-7315-105-2-160-b36","series-title":"J Am Acad Orthop Surg","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5435\/00124635-200708000-00002","article-title":"The effects of medications on bone","volume":"15","author":"Goodman\n              SB,","year":"2007","unstructured":"Goodman\n              SB, \n            \n              Jiranek\n              W, \n            \n              Petrow\n              E, \n            et al\n          : The effects of medications on bone. J Am Acad Orthop Surg15: 450, 2007.10.5435\/00124635-200708000-00002"},{"key":"i8750-7315-105-2-160-b37","series-title":"J Clin Psychiatry","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.4088\/JCP.v65n1205","article-title":"Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism","volume":"65","author":"Misra\n              M,","year":"2004","unstructured":"Misra\n              M, \n            \n              Papalostas\n              GI, \n            \n              Kibanski\n              A:\n            \n          \n          Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry65: 1607, 2004.10.4088\/JCP.v65n120515641865"},{"key":"i8750-7315-105-2-160-b38","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/mds.22679","article-title":"Atypical antipsychotic use and risk of fracture in persons with parkinsonism","volume":"24","author":"Dore\n              DD,","year":"2009","unstructured":"Dore\n              DD, \n            \n              Trivedi\n              AN, \n            \n              Mor\n              V, \n            et al\n          : Atypical antipsychotic use and risk of fracture in persons with parkinsonism. Mov Disord24: 1941, 2009.1964506610.1002\/mds.22679"},{"key":"i8750-7315-105-2-160-b39","series-title":"Calcif Tissue Int","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00223-007-9099-9","article-title":"Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture","volume":"82","author":"Vestergaard\n              P,","year":"2008","unstructured":"Vestergaard\n              P, \n            \n              Rejnmark\n              L, \n            \n              Mosekilde\n              L:\n            \n          \n          Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int82: 92, 2008.10.1007\/s00223-007-9099-918219438"},{"key":"i8750-7315-105-2-160-b40","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","article-title":"Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture","volume":"17","author":"Vestergaard\n              P,","year":"2006","unstructured":"Vestergaard\n              P, \n            \n              Rejnmark\n              L, \n            \n              Mosekilde\n              L:\n            \n          \n          Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int17: 807, 2006.1652088910.1007\/s00198-005-0065-y"},{"key":"i8750-7315-105-2-160-b41","series-title":"Curr Drug Saf","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/157488608785699405","article-title":"Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy","volume":"3","author":"Vestergaard\n              P:","year":"2008","unstructured":"Vestergaard\n              P:\n            \n          \n          Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy. Curr Drug Saf3: 168, 2008.1869099610.2174\/157488608785699405"},{"key":"i8750-7315-105-2-160-b42","series-title":"Arch Neurol","first-page":"107","article-title":"Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis","volume":"68","author":"Jett\u00e9\n              N,","year":"2001","unstructured":"Jett\u00e9\n              N, \n            \n              Lix\n              LM, \n            \n              Metge\n              CJ, \n            et al\n          : Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Arch Neurol68: 107, 2001."},{"key":"i8750-7315-105-2-160-b43","series-title":"Curr Osteoporos Rep","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11914-010-0027-y","article-title":"Bone loss in diabetes: use of antidiabetic thiazolidediones and secondary osteoporosis","volume":"8","author":"Lecka-Czernik\n              B:","year":"2010","unstructured":"Lecka-Czernik\n              B:\n            \n          \n          Bone loss in diabetes: use of antidiabetic thiazolidediones and secondary osteoporosis. Curr Osteoporos Rep8: 178, 2010.10.1007\/s11914-010-0027-y"},{"key":"i8750-7315-105-2-160-b44","series-title":"Injury","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.injury.2007.10.035","article-title":"Pharmacological agents and impairment of fracture healing: what is the evidence?","volume":"39","author":"Pountos\n              I,","year":"2008","unstructured":"Pountos\n              I, \n            \n              Georgouli\n              T, \n            \n              Blokhuis\n              TJ, \n            et al\n          : Pharmacological agents and impairment of fracture healing: what is the evidence?Injury39: 384, 2008.1831608310.1016\/j.injury.2007.10.035"},{"key":"i8750-7315-105-2-160-b45","series-title":"J Clin Endocrinol Metab","first-page":"883","article-title":"The localization of the functional glucorticoid receptor alpha in human bone","volume":"85","author":"Abu\n              EO,","year":"2000","unstructured":"Abu\n              EO, \n            \n              Horner\n              A, \n            \n              Kusec\n              V, \n            et al\n          : The localization of the functional glucorticoid receptor alpha in human bone. J Clin Endocrinol Metab85: 883, 2000."},{"key":"i8750-7315-105-2-160-b46","series-title":"Joint Bone Spine","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1297-319X(03)00016-2","article-title":"Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments","volume":"70","author":"Lafage-Proust\n              MH,","year":"2003","unstructured":"Lafage-Proust\n              MH, \n            \n              Boudignon\n              B, \n            \n              Thomas\n              T:\n            \n          \n          Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments. Joint Bone Spine70: 109, 2003.10.1016\/S1297-319X(03)00016-212713854"},{"key":"i8750-7315-105-2-160-b47","series-title":"Calcif Tissue Int","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00223-002-0027-8","article-title":"Thyroid hormones: beneficial or deleterious for bone?","volume":"73","author":"Lakatos\n              P:","year":"2003","unstructured":"Lakatos\n              P:\n            \n          \n          Thyroid hormones: beneficial or deleterious for bone?\n          Calcif Tissue Int\n          73: 205, 2003.10.1007\/s00223-002-0027-8"},{"key":"i8750-7315-105-2-160-b48","series-title":"Basic Clin Pharmacol Toxicol","first-page":"10","article-title":"Non-steroidal anti-inflammatory drugs cyclooxygenase-2 and the bone healing process","volume":"102","author":"Vuolteenaho\n              K,","year":"2008","unstructured":"Vuolteenaho\n              K, \n            \n              Moilanen\n              T, \n            \n              Moilanen\n              E:\n            \n          \n          Non-steroidal anti-inflammatory drugs cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol102: 10, 2008.17973900"},{"key":"i8750-7315-105-2-160-b49","series-title":"J Bone Joint Surg Br","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1302\/0301-620X.82B5.0820655","article-title":"Nonunion of the femoral diaphysis: the influence of reaming and nonsteroidal anti-inflammatory drugs","volume":"82","author":"Giannoudis\n              PV,","year":"2000","unstructured":"Giannoudis\n              PV, \n            \n              MacDonald\n              DA, \n            \n              Matthews\n              SJ, \n            et al\n          : Nonunion of the femoral diaphysis: the influence of reaming and nonsteroidal anti-inflammatory drugs. J Bone Joint Surg Br82: 655, 2000.10.1302\/0301-620X.82B5.082065510963160"},{"key":"i8750-7315-105-2-160-b50","series-title":"Calcif Tissue Int","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00223-010-9379-7","article-title":"NSAID exposure and risk of nonunion: a meta-analysis of case control and cohort studies","volume":"87","author":"Dodwell\n              ER,","year":"2010","unstructured":"Dodwell\n              ER, \n            \n              Latorre\n              JG\n            \n            \n              Parisini\n              E, \n            et al\n          : NSAID exposure and risk of nonunion: a meta-analysis of case control and cohort studies. Calcif Tissue Int87: 193, 2010.2055233310.1007\/s00223-010-9379-7"},{"key":"i8750-7315-105-2-160-b51","series-title":"ScientificWorldJournal","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/606404","article-title":"Do nonsteroidal anti-inflammatory drugs affect bone healing? a critical analysis","author":"Pountos\n              I,","year":"2012","unstructured":"Pountos\n              I, \n            \n              Georgouli\n              T, \n            \n              Calori\n              GM, \n            et al\n          : Do nonsteroidal anti-inflammatory drugs affect bone healing? a critical analysis[published online January 4, 2012]. ScientificWorldJournal2012. doi:10.1100\/2012\/606404.22272177"},{"key":"i8750-7315-105-2-160-b52","series-title":"Calcif Tissue Int","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","article-title":"Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture","volume":"79","author":"Vestergaard\n              P,","year":"2006","unstructured":"Vestergaard\n              P, \n            \n              Rejnmark\n              L, \n            \n              Mosekilde\n              L:\n            \n          \n          Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int79: 76, 2006.10.1007\/s00223-006-0021-716927047"},{"key":"i8750-7315-105-2-160-b53","series-title":"Injury","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.injury.2011.08.019","article-title":"Osteoporosis is not a risk factor for the development of nonunion: a cohort nested case-control study","volume":"42","author":"Van Wunnik\n              BP,","year":"2011","unstructured":"Van Wunnik\n              BP, \n            \n              Weijers\n              PH, \n            \n              van Helden\n              SH, \n            et al\n          : Osteoporosis is not a risk factor for the development of nonunion: a cohort nested case-control study. Injury42: 1491, 2011.10.1016\/j.injury.2011.08.019"}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/105\/2\/0003-0538-105.2.160.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/japma\/article-pdf\/105\/2\/160\/1604728\/0003-0538-105_2_160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/105\/2\/0003-0538-105.2.160.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/105\/2\/0003-0538-105.2.160.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:12:57Z","timestamp":1783505577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/105\/2\/160"}},"subtitle":["An Appraisal of the Effects of Frequently Prescribed Medications"],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":53,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.7547\/0003-0538-105.2.160","relation":{},"ISSN":["8750-7315","1930-8264"],"issn-type":[{"value":"8750-7315","type":"print"},{"value":"1930-8264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}